Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CXCL13/BCA-1 Antibody (6I514) (Synonyms: SCYB13, chemokine (C-X-C motif) ligand 13, BLR1L, BLC, BCA-1||...)

Catalog No. TMAY-03664 Copy Product Info
🥰Excellent
Anti-CXCL13/BCA-1 Antibody (6I514) is a Mouse antibody targeting CXCL13/BCA-1. Anti-CXCL13/BCA-1 Antibody (6I514) can be used in ELISA.

Anti-CXCL13/BCA-1 Antibody (6I514)

Copy Product Info
🥰Excellent
Catalog No. TMAY-03664
Synonyms SCYB13, chemokine (C-X-C motif) ligand 13, BLR1L, BLC, BCA-1, BCA1, ANGIE2, ANGIE

Anti-CXCL13/BCA-1 Antibody (6I514) is a Mouse antibody targeting CXCL13/BCA-1. Anti-CXCL13/BCA-1 Antibody (6I514) can be used in ELISA.

Anti-CXCL13/BCA-1 Antibody
(6I514)
Pack SizePriceUSA StockGlobal StockQuantity
100 μL$1987-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-CXCL13/BCA-1 Antibody (6I514) is a Mouse antibody targeting CXCL13/BCA-1. Anti-CXCL13/BCA-1 Antibody (6I514) can be used in ELISA.
SynonymsSCYB13, chemokine (C-X-C motif) ligand 13, BLR1L, BLC, BCA-1, BCA1, ANGIE2, ANGIE
Ig Type
Mouse IgG1
Clone
6I514
Reactivity
Canine
Specificity
Canine BCA-1/CXCL13
Application
Recommended Dose
ELISA: 1:1000-1:2000
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Canine BCA-1 / CXCL13 ( TMPY-03708; XP_851619.3; Val23-Asn110). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundThe chemokine CXCL13, also known as BCA-1 (B-cell-attracting chemokine-1) or BLC (B-lymphocyte chemoattractant), which belongs to the CXC chemokine family. CXCL13 and its receptor CXCR5 control the organization of B cells within follicles of lymphoid tissues. CXCL13 is known to dictate homing and motility of B cells in lymphoid tissue and has been implicated in the formation of ectopic lymphoid tissue in chronic inflammation. It involves in B-cell compartmental homing within secondary lymphoid organs and recently implicated in the pathogenesis of inflammatory and malignant lymphocyte-mediated diseases. In Primary central nervous system lymphoma (PCNSL), expression of BCA-1 by malignant lymphocytes and vascular endothelium may influence tumor development and localization to central nervous system (CNS). In T-lymphocytes, CXCL13 expression is thought to reflect a germinal center origin of the T-cell. CXCL13 expression may also provide an additional useful tool for the diagnosis of Angioimmunoblastic T-cell lymphoma (AITL).
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Canine BCA-1 / CXCL13 Protein (TMPY-03708)
Antigen Species
Canine
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-CXCL13/BCA-1 Antibody (6I514) | purchase Anti-CXCL13/BCA-1 Antibody (6I514) | Anti-CXCL13/BCA-1 Antibody (6I514) cost | order Anti-CXCL13/BCA-1 Antibody (6I514)